Citadel Advisors
DARE icon

Citadel Advisors’s Dare Bioscience DARE Stock Holding History

Citadel Advisors’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,440
Closed -$79.1K – 14418
2024
Q1 		$79.1K Buy
+13,440
New +$65.8K ﹤0.01% 11667
2023
Q4 		– Sell
-11,032
Closed -$61.1K – 14399
2023
Q3 		$61.1K Buy
11,032
+6,874
+165% +$56.6K ﹤0.01% 11506
2023
Q2 		$45.4K Sell
4,158
-16,229
-80% -$193K ﹤0.01% 11915
2023
Q1 		$254K Buy
+20,387
New +$271K ﹤0.01% 9720
2022
Q2 		– Sell
-3,532
Closed -$63K – 13046
2022
Q1 		$63K Buy
+3,532
New +$66.8K ﹤0.01% 12647
2021
Q4 		– Sell
-5,551
Closed -$111K – 13923
2021
Q3 		$111K Buy
+5,551
New +$109K ﹤0.01% 12743
2021
Q1 		– Sell
-5,381
Closed -$87K – 13231
2020
Q4 		$87K Buy
+5,381
New +$75.4K ﹤0.01% 10299
2019
Q2 		– Sell
-1,355
Closed -$23K – 9263
2019
Q1 		$23K Buy
+1,355
New +$15.8K ﹤0.01% 9040
2018
Q4 		– Sell
-8,862
Closed -$104K – 9208
2018
Q3 		$104K Buy
8,862
+5,956
+205% +$80.2K ﹤0.01% 8559
2018
Q2 		$41K Buy
+2,906
New +$38.8K ﹤0.01% 8478
2018
Q1 		– Sell
-940
Closed -$24K – 8342
2017
Q4 		$24K Buy
+940
New +$30.2K ﹤0.01% 7801
2017
Q3 		– Sell
-84
Closed -$4K – 7600
2017
Q2 		$4K Sell
84
-228
-73% -$13.3K ﹤0.01% 7394
2017
Q1 		$30K Buy
+312
New +$45K ﹤0.01% 7169
2016
Q3 		– Sell
-133
Closed -$34K – 7304
2016
Q2 		$34K Buy
+133
New +$42.6K ﹤0.01% 6492

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Citadel Advisors's DARE Position: Q2 2024 in Review

Citadel Advisors sold out of Dare Bioscience (DARE) in Q2 2024, closing a stake of 13,440 shares — an estimated $79.1K sold.

Citadel Advisors first reported a position in DARE in Q2 2016 and held it in 14 quarters. The position peaked at $254K in Q1 2023. 27 funds tracked by Wall St. Rank hold DARE as of Q2 2024.

  • Citadel Advisors reported no remaining Dare Bioscience position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 13,440 Dare Bioscience shares in Q2 2024, an estimated $79.1K.
  • Citadel Advisors first reported a position in Dare Bioscience in Q2 2016 and held it in 14 quarters.
  • Citadel Advisors's Dare Bioscience position peaked at $254K in Q1 2023.
  • 27 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.